An inverse relationship between the growth rate of human melanoma xenografts and their response to some cytostatic drugs.
作者信息
Fodstad O, Aass N, Pihl A
出版信息
Br J Cancer. 1980 May;41(5):829-31. doi: 10.1038/bjc.1980.149.
Abstract
摘要
相似文献
1
An inverse relationship between the growth rate of human melanoma xenografts and their response to some cytostatic drugs.人黑色素瘤异种移植物的生长速率与其对某些细胞抑制药物的反应之间存在负相关关系。
Br J Cancer. 1980 May;41(5):829-31. doi: 10.1038/bjc.1980.149.
2
Response to chemotherapy of human, malignant melanoma xenografts in athymic, nude mice.无胸腺裸鼠体内人恶性黑色素瘤异种移植瘤对化疗的反应
Int J Cancer. 1980 Apr 15;25(4):453-8. doi: 10.1002/ijc.2910250405.
3
Chemotherapy of a human malignant melanoma transplanted in the nude mouse.对移植于裸鼠体内的人类恶性黑色素瘤进行化疗。
Cancer Res. 1975 Oct;35(10):2790-6.
4
In vitro sensitivity of human melanoma xenografts to cytotoxic drugs. Correlation with in vivo chemosensitivity.人黑色素瘤异种移植瘤对细胞毒性药物的体外敏感性。与体内化学敏感性的相关性。
Int J Cancer. 1980 Dec 15;26(6):717-22. doi: 10.1002/ijc.2910260604.
5
Use of methyl-CCNU and procarbazine in advanced malignant melanoma resistant to DTIC therapy.甲基环己亚硝脲和丙卡巴肼在对达卡巴嗪治疗耐药的晚期恶性黑色素瘤中的应用。
Cancer Treat Rep. 1977 Dec;61(9):1738-9.
6
DTIC (NSC-45388) in malignant melanoma: a perspective.达卡巴嗪（NSC-45388）在恶性黑色素瘤中的应用：综述
Cancer Treat Rep. 1976 Feb;60(2):165-76.
7
8
Combination chemotherapy in disseminated melanoma and other solid tumors in adults.成人播散性黑色素瘤及其他实体瘤的联合化疗
Oncology. 1975;31(1):22-30. doi: 10.1159/000225002.
9
Chemotherapy of malignant melanoma.恶性黑色素瘤的化疗
World J Surg. 1979 Jul 30;3(3):321-8. doi: 10.1007/BF01556584.
10
Chemotherapy of experimental metastatic brain tumors in female Wistar rats.
Cancer Res. 1979 Jul;39(7 Pt 1):2691-7.
引用本文的文献
1
DUXAP8 knockdown inhibits the development of melanoma by regulating the miR-3182/NUPR1 pathway.DUXAP8基因敲低通过调控miR-3182/NUPR1通路抑制黑色素瘤的发展。
Oncol Lett. 2021 Jul;22(1):495. doi: 10.3892/ol.2021.12756. Epub 2021 Apr 27.
2
Pharmacological studies of ricin in mice and humans.蓖麻毒素在小鼠和人类中的药理学研究。
Cancer Chemother Pharmacol. 1984;13(3):157-63. doi: 10.1007/BF00269021.
本文引用的文献
1
Chemotherapy of malignant melanoma.恶性黑色素瘤的化疗
Cancer. 1972 Dec;30(6):1604-15. doi: 10.1002/1097-0142(197212)30:6<1604::aid-cncr2820300629>3.0.co;2-5.
2
The relationship between growth rate, labelling index and histological type of human solid tumours.
Eur J Cancer (1965). 1973 Apr;9(4):305-12. doi: 10.1016/0014-2964(73)90099-6.
3
Proliferation-dependent cytotoxicity of anticancer agents: a review.抗癌药物的增殖依赖性细胞毒性：综述
Cancer Res. 1975 Oct;35(10):2619-30.
4
5
DTIC (NSC-45388) in malignant melanoma: a perspective.达卡巴嗪（NSC-45388）在恶性黑色素瘤中的应用：综述
Cancer Treat Rep. 1976 Feb;60(2):165-76.
6
Variation in response of xenografts of colo-rectal carcinoma to chemotherapy.结直肠癌异种移植对化疗反应的差异。
Br J Cancer. 1978 Apr;37(4):576-84. doi: 10.1038/bjc.1978.87.
7
The growth and therapeutic response of human tumours in immune deficient mice.
Bull Cancer. 1978;65(4):465-72.
8
Selective toxicity of anticancer drugs: Presidential Address.抗癌药物的选择性毒性：主席致辞
Cancer Res. 1978 Dec;38(12):4377-84.
9
An in vitro colony assay for human tumours grown in immune-suppressed mice and treated in vivo with cytotoxic agents.一种用于在免疫抑制小鼠体内生长并在体内用细胞毒性药物治疗的人类肿瘤的体外集落测定法。
Br J Cancer. 1978 Feb;37(2):261-8. doi: 10.1038/bjc.1978.35.
10
Chemotherapy of human colon cancer xenografts in athymic nude mice.无胸腺裸鼠人结肠癌异种移植瘤的化疗
Cancer. 1977 Nov;40(5 Suppl):2640-50. doi: 10.1002/1097-0142(197711)40:5+<2640::aid-cncr2820400938>3.0.co;2-1.
Zotero 插件